<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font3" size="7" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font4" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font5" size="11" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font6" size="9" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font7" size="6" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font8" size="6" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font9" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font10" size="8" family="SymbolMT" color="#000000"/>
<text top="42" left="315" width="241" height="7" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="text">Available online http://breast-cancer-research.com/content/9/1/R11<b>Available online</b></text>
<text top="758" left="511" width="45" height="7" font="font2" id="p1_t2" reading_order_no="115" segment_no="16" tag_type="text">Page 5 of 11</text>
<text top="769" left="436" width="120" height="6" font="font3" id="p1_t3" reading_order_no="116" segment_no="17" tag_type="text">(page number not for citation purposes)</text>
<text top="297" left="57" width="240" height="9" font="font4" id="p1_t4" reading_order_no="49" segment_no="5" tag_type="text">Smoking status, alcohol habits and physical activity were not<i>(page number not for citation purposes)</i></text>
<text top="308" left="57" width="240" height="9" font="font4" id="p1_t5" reading_order_no="50" segment_no="5" tag_type="text">associated with any specific subgroup of breast cancer (data</text>
<text top="320" left="57" width="46" height="9" font="font4" id="p1_t6" reading_order_no="51" segment_no="5" tag_type="text">not shown).</text>
<text top="343" left="57" width="57" height="10" font="font5" id="p1_t7" reading_order_no="52" segment_no="7" tag_type="title">Discussion</text>
<text top="355" left="57" width="240" height="9" font="font4" id="p1_t8" reading_order_no="53" segment_no="8" tag_type="text">We found that low intakes of energy and total fat (especially<b>Discussion</b></text>
<text top="367" left="57" width="240" height="9" font="font4" id="p1_t9" reading_order_no="54" segment_no="8" tag_type="text">PUFA), and high BMI were associated with more malignant</text>
<text top="379" left="57" width="56" height="9" font="font4" id="p1_t10" reading_order_no="55" segment_no="8" tag_type="text">breast cancer.</text>
<text top="402" left="57" width="240" height="9" font="font4" id="p1_t11" reading_order_no="56" segment_no="10" tag_type="text">Some methodological issues must be addressed. Dietary</text>
<text top="414" left="57" width="240" height="9" font="font4" id="p1_t12" reading_order_no="57" segment_no="10" tag_type="text">assessment may be biased because of measurement error, for</text>
<text top="426" left="57" width="240" height="9" font="font4" id="p1_t13" reading_order_no="58" segment_no="10" tag_type="text">instance over- and under-reporting. The validity of dietary data</text>
<text top="438" left="57" width="240" height="9" font="font4" id="p1_t14" reading_order_no="59" segment_no="10" tag_type="text">in the MDCS has been examined using 18 days of weighed</text>
<text top="449" left="57" width="241" height="9" font="font4" id="p1_t15" reading_order_no="60" segment_no="10" tag_type="text">food records collected over 1 year in a subgroup of MDCS</text>
<text top="461" left="57" width="240" height="9" font="font4" id="p1_t16" reading_order_no="61" segment_no="10" tag_type="text">participants (126 men and 115 women) and validity was found</text>
<text top="473" left="57" width="74" height="9" font="font4" id="p1_t17" reading_order_no="62" segment_no="10" tag_type="text">to be high [22,23].</text>
<text top="496" left="57" width="240" height="9" font="font4" id="p1_t18" reading_order_no="63" segment_no="11" tag_type="text">Whether energy-adjusted variables should be used when ana-<a href="">to be high [22,23].</a></text>
<text top="508" left="57" width="240" height="9" font="font4" id="p1_t19" reading_order_no="64" segment_no="11" tag_type="text">lyzing any relation between dietary intake and disease is a</text>
<text top="520" left="57" width="240" height="9" font="font4" id="p1_t20" reading_order_no="65" segment_no="11" tag_type="text">matter of controversy among nutritional researchers [26,27],</text>
<text top="532" left="57" width="240" height="9" font="font4" id="p1_t21" reading_order_no="66" segment_no="11" tag_type="text">and in this study we present results using the total, as well as<a href="">ers [26,27],</a></text>
<text top="543" left="57" width="164" height="9" font="font4" id="p1_t22" reading_order_no="67" segment_no="11" tag_type="text">energy-adjusted, intake of macronutrients.</text>
<text top="567" left="57" width="240" height="9" font="font4" id="p1_t23" reading_order_no="68" segment_no="13" tag_type="text">A prevalent or subclinical breast cancer may affect anthropo-</text>
<text top="579" left="57" width="240" height="9" font="font4" id="p1_t24" reading_order_no="69" segment_no="13" tag_type="text">metric measurements and dietary habits. All data concerning</text>
<text top="590" left="57" width="240" height="9" font="font4" id="p1_t25" reading_order_no="70" segment_no="13" tag_type="text">objective body measurements were gathered between 0.2</text>
<text top="602" left="57" width="240" height="9" font="font4" id="p1_t26" reading_order_no="71" segment_no="13" tag_type="text">and 10.4 (mean 4.3) years before breast cancer diagnosis,</text>
<text top="614" left="57" width="240" height="9" font="font4" id="p1_t27" reading_order_no="72" segment_no="13" tag_type="text">and the values were therefore most likely unaffected by dis-</text>
<text top="626" left="57" width="240" height="9" font="font4" id="p1_t28" reading_order_no="73" segment_no="13" tag_type="text">ease. Supporting this interpretation is the lack of relation</text>
<text top="637" left="57" width="240" height="9" font="font4" id="p1_t29" reading_order_no="74" segment_no="13" tag_type="text">between BMI and time to diagnosis ( P = 0.526, r = -0.021</text>
<text top="649" left="57" width="240" height="9" font="font4" id="p1_t30" reading_order_no="75" segment_no="13" tag_type="text">[Spearman's correlation test]). Similar results were obtained</text>
<text top="661" left="57" width="240" height="9" font="font4" id="p1_t31" reading_order_no="76" segment_no="13" tag_type="text">for energy intake and time to diagnosis ( P = 0.208, r = -<i>P </i></text>
<text top="673" left="57" width="29" height="9" font="font4" id="p1_t32" reading_order_no="77" segment_no="13" tag_type="text">0.060).</text>
<text top="696" left="57" width="240" height="9" font="font4" id="p1_t33" reading_order_no="78" segment_no="15" tag_type="text">Tumour classification with regard to type and grade was per-<i>r </i></text>
<text top="708" left="57" width="240" height="9" font="font4" id="p1_t34" reading_order_no="79" segment_no="15" tag_type="text">formed according to current classification systems. The tissue</text>
<text top="720" left="57" width="240" height="9" font="font4" id="p1_t35" reading_order_no="80" segment_no="15" tag_type="text">microarray (TMA) technique used in this study is now a well</text>
<text top="297" left="315" width="240" height="9" font="font4" id="p1_t36" reading_order_no="81" segment_no="6" tag_type="text">documented method for high-throughput tissue screening,</text>
<text top="308" left="315" width="240" height="9" font="font4" id="p1_t37" reading_order_no="82" segment_no="6" tag_type="text">with two tissue cores considered a sufficient sampling amount<i>P </i></text>
<text top="320" left="315" width="240" height="9" font="font4" id="p1_t38" reading_order_no="83" segment_no="6" tag_type="text">[28,29]. The distribution of the immunohistochemical markers</text>
<text top="332" left="315" width="241" height="9" font="font4" id="p1_t39" reading_order_no="84" segment_no="6" tag_type="text">was in accordance with earlier studies [16], thus validating the<i>r </i></text>
<text top="344" left="315" width="53" height="9" font="font4" id="p1_t40" reading_order_no="85" segment_no="6" tag_type="text">assessments.</text>
<text top="367" left="315" width="240" height="9" font="font4" id="p1_t41" reading_order_no="86" segment_no="9" tag_type="text">The participation rate in the MDCS was about 40% of the</text>
<text top="379" left="315" width="240" height="9" font="font4" id="p1_t42" reading_order_no="87" segment_no="9" tag_type="text">potential participant population. The participants did have a</text>
<text top="391" left="315" width="240" height="9" font="font4" id="p1_t43" reading_order_no="88" segment_no="9" tag_type="text">higher incidence of breast cancer compared with the source</text>
<text top="402" left="315" width="240" height="9" font="font4" id="p1_t44" reading_order_no="89" segment_no="9" tag_type="text">population [21] and were most likely a selected group in terms</text>
<text top="414" left="315" width="240" height="9" font="font4" id="p1_t45" reading_order_no="90" segment_no="9" tag_type="text">of socioeconomic factors. Nevertheless, the distribution of his-</text>
<text top="426" left="315" width="240" height="9" font="font4" id="p1_t46" reading_order_no="91" segment_no="9" tag_type="text">tological type and grade within the incident breast tumours in</text>
<text top="438" left="315" width="240" height="9" font="font4" id="p1_t47" reading_order_no="92" segment_no="9" tag_type="text">this study was similar to that in other studies [11,30]. Even if<a href="">[28,29]</a>. The distribution of the immunohistochemical markers</text>
<text top="449" left="315" width="240" height="9" font="font4" id="p1_t48" reading_order_no="93" segment_no="9" tag_type="text">our breast cancer population were different from the back-<a href="">s [16]</a>, thus validating the</text>
<text top="461" left="315" width="240" height="9" font="font4" id="p1_t49" reading_order_no="94" segment_no="9" tag_type="text">ground population, it would still be possible to make internal</text>
<text top="473" left="315" width="240" height="9" font="font4" id="p1_t50" reading_order_no="95" segment_no="9" tag_type="text">comparisons between different tumour groups in terms of die-</text>
<text top="485" left="315" width="155" height="9" font="font4" id="p1_t51" reading_order_no="96" segment_no="9" tag_type="text">tary and anthropometric measurements.</text>
<text top="508" left="315" width="240" height="9" font="font4" id="p1_t52" reading_order_no="97" segment_no="12" tag_type="text">Because several methodological factors in the MDCS may</text>
<text top="520" left="315" width="240" height="9" font="font4" id="p1_t53" reading_order_no="98" segment_no="12" tag_type="text">affect dietary measurements, all analyses were adjusted for<a href="">[21] a</a>nd were most likely a selected group in terms</text>
<text top="532" left="315" width="240" height="9" font="font4" id="p1_t54" reading_order_no="99" segment_no="12" tag_type="text">diet assistant, period of data collection, diet methodology and</text>
<text top="543" left="315" width="240" height="9" font="font4" id="p1_t55" reading_order_no="100" segment_no="12" tag_type="text">past food habit change, as well as for total energy intake when</text>
<text top="555" left="315" width="240" height="9" font="font4" id="p1_t56" reading_order_no="101" segment_no="12" tag_type="text">stated. Hence, these factors ought not to have confounded<a href="">in other studies [11,30]. Even if</a></text>
<text top="567" left="315" width="240" height="9" font="font4" id="p1_t57" reading_order_no="102" segment_no="12" tag_type="text">dietary assessments. It was decided not to adjust the present</text>
<text top="579" left="315" width="240" height="9" font="font4" id="p1_t58" reading_order_no="103" segment_no="12" tag_type="text">analysis for established risk factors for breast cancer or factors</text>
<text top="590" left="315" width="241" height="9" font="font4" id="p1_t59" reading_order_no="104" segment_no="12" tag_type="text">that affect true dietary intake (for example socioeconomic</text>
<text top="602" left="315" width="240" height="9" font="font4" id="p1_t60" reading_order_no="105" segment_no="12" tag_type="text">index), because the main objective was to conduct perform a</text>
<text top="614" left="315" width="240" height="9" font="font4" id="p1_t61" reading_order_no="106" segment_no="12" tag_type="text">descriptive and exploratory analysis of dietary intake in differ-</text>
<text top="626" left="315" width="240" height="9" font="font4" id="p1_t62" reading_order_no="107" segment_no="12" tag_type="text">ent groups of breast cancer as defined by pathological and</text>
<text top="637" left="315" width="82" height="9" font="font4" id="p1_t63" reading_order_no="108" segment_no="12" tag_type="text">biological properties.</text>
<text top="661" left="315" width="240" height="9" font="font4" id="p1_t64" reading_order_no="109" segment_no="14" tag_type="text">The present study includes a large number of comparisons,</text>
<text top="673" left="315" width="241" height="9" font="font4" id="p1_t65" reading_order_no="110" segment_no="14" tag_type="text">and P values should be interpreted with caution. Because no</text>
<text top="684" left="315" width="241" height="9" font="font4" id="p1_t66" reading_order_no="111" segment_no="14" tag_type="text">previous study has addressed the same issue using our meth-</text>
<text top="696" left="315" width="240" height="9" font="font4" id="p1_t67" reading_order_no="112" segment_no="14" tag_type="text">odology, we consider the present analyses as a first, hypo-</text>
<text top="708" left="315" width="240" height="9" font="font4" id="p1_t68" reading_order_no="113" segment_no="14" tag_type="text">thesis-generating study. Our findings need confirmation in</text>
<text top="720" left="315" width="197" height="9" font="font4" id="p1_t69" reading_order_no="114" segment_no="14" tag_type="text">future studies including healthy control individuals.</text>
<text top="85" left="57" width="28" height="7" font="font0" id="p1_t70" reading_order_no="1" segment_no="1" tag_type="title">Table 2</text>
<text top="104" left="57" width="352" height="9" font="font0" id="p1_t71" reading_order_no="2" segment_no="2" tag_type="text">Associations between tumour type, grade, ER, cyclin D 1 , cyclin E, p27 and proliferation (Ki67)</text>
<text top="124" left="121" width="26" height="7" font="font2" id="p1_t72" reading_order_no="3" segment_no="3" tag_type="table">Tumour</text>
<text top="132" left="121" width="26" height="7" font="font2" id="p1_t73" reading_order_no="4" segment_no="3" tag_type="table">grading</text>
<text top="124" left="164" width="50" height="7" font="font2" id="p1_t74" reading_order_no="5" segment_no="3" tag_type="table">Nucleus grade</text>
<text top="124" left="230" width="10" height="7" font="font2" id="p1_t75" reading_order_no="6" segment_no="3" tag_type="table">ER<i>P </i></text>
<text top="124" left="298" width="32" height="9" font="font2" id="p1_t76" reading_order_no="7" segment_no="3" tag_type="table">Cyclin D 1</text>
<text top="124" left="359" width="28" height="7" font="font2" id="p1_t77" reading_order_no="8" segment_no="3" tag_type="table">Cyclin E</text>
<text top="124" left="427" width="14" height="7" font="font2" id="p1_t78" reading_order_no="9" segment_no="3" tag_type="table">p27</text>
<text top="124" left="495" width="16" height="7" font="font2" id="p1_t79" reading_order_no="10" segment_no="3" tag_type="table">Ki67</text>
<text top="148" left="60" width="45" height="7" font="font2" id="p1_t80" reading_order_no="11" segment_no="3" tag_type="table">Tumour type a</text>
<text top="148" left="120" width="80" height="7" font="font2" id="p1_t81" reading_order_no="12" segment_no="3" tag_type="table">(&lt;0.001**) (&lt;0.001**)<b>Table 2</b></text>
<text top="148" left="229" width="24" height="7" font="font2" id="p1_t82" reading_order_no="13" segment_no="3" tag_type="table">(0.01*)<b>Associations between tumour type, grade, ER, cyclin D</b></text>
<text top="148" left="297" width="21" height="7" font="font2" id="p1_t83" reading_order_no="14" segment_no="3" tag_type="table">(0.11)<b>1</b></text>
<text top="148" left="358" width="21" height="7" font="font2" id="p1_t84" reading_order_no="15" segment_no="3" tag_type="table">(0.10)<b>, cyclin E, p27 and proliferation (Ki67)</b></text>
<text top="148" left="426" width="21" height="7" font="font2" id="p1_t85" reading_order_no="16" segment_no="3" tag_type="table">(0.67)</text>
<text top="148" left="494" width="31" height="7" font="font2" id="p1_t86" reading_order_no="17" segment_no="3" tag_type="table">(0.009**)</text>
<text top="164" left="60" width="74" height="7" font="font2" id="p1_t87" reading_order_no="18" segment_no="3" tag_type="table">Tumour grading 1 (-)</text>
<text top="164" left="163" width="182" height="7" font="font2" id="p1_t88" reading_order_no="19" segment_no="3" tag_type="table">0.789 (&lt;0.001**) -0.374 (&lt;0.001**) 0.082 (0.155)</text>
<text top="164" left="358" width="59" height="7" font="font2" id="p1_t89" reading_order_no="20" segment_no="3" tag_type="table">0.339 (&lt;0.001**)</text>
<text top="164" left="426" width="128" height="7" font="font2" id="p1_t90" reading_order_no="21" segment_no="3" tag_type="table">-0.271 (&lt;0.001**) 0.530 (&lt;0.001**)</text>
<text top="179" left="60" width="50" height="7" font="font2" id="p1_t91" reading_order_no="22" segment_no="3" tag_type="table">Nucleus grade</text>
<text top="179" left="163" width="14" height="7" font="font2" id="p1_t92" reading_order_no="23" segment_no="3" tag_type="table">1 (-)</text>
<text top="179" left="229" width="59" height="7" font="font2" id="p1_t93" reading_order_no="24" segment_no="3" tag_type="table">-0.369 (&lt;0.001**</text>
<text top="179" left="297" width="48" height="7" font="font2" id="p1_t94" reading_order_no="25" segment_no="3" tag_type="table">0.050 (0.391)</text>
<text top="179" left="358" width="59" height="7" font="font2" id="p1_t95" reading_order_no="26" segment_no="3" tag_type="table">0.323 (&lt;0.001**)</text>
<text top="179" left="426" width="50" height="7" font="font2" id="p1_t96" reading_order_no="27" segment_no="3" tag_type="table">-0.188 (0.001)</text>
<text top="179" left="494" width="59" height="7" font="font2" id="p1_t97" reading_order_no="28" segment_no="3" tag_type="table">0.448 (&lt;0.001**)</text>
<text top="195" left="60" width="10" height="7" font="font2" id="p1_t98" reading_order_no="29" segment_no="3" tag_type="table">ER</text>
<text top="195" left="229" width="14" height="7" font="font2" id="p1_t99" reading_order_no="30" segment_no="3" tag_type="table">1 (-)</text>
<text top="195" left="297" width="188" height="7" font="font2" id="p1_t100" reading_order_no="31" segment_no="3" tag_type="table">0.154 (0.007**) -0.540 (&lt;0.001**) 0.291 (&lt;0.001**)</text>
<text top="195" left="494" width="62" height="7" font="font2" id="p1_t101" reading_order_no="32" segment_no="3" tag_type="table">-0.282 (&lt;0.001**)</text>
<text top="210" left="60" width="32" height="9" font="font2" id="p1_t102" reading_order_no="33" segment_no="3" tag_type="table">Cyclin D 1</text>
<text top="210" left="297" width="14" height="7" font="font2" id="p1_t103" reading_order_no="34" segment_no="3" tag_type="table">1 (-)</text>
<text top="210" left="358" width="48" height="7" font="font2" id="p1_t104" reading_order_no="35" segment_no="3" tag_type="table">0.024 (0.674)</text>
<text top="210" left="426" width="59" height="7" font="font2" id="p1_t105" reading_order_no="36" segment_no="3" tag_type="table">0.262 (&lt;0.001**)</text>
<text top="210" left="494" width="59" height="7" font="font2" id="p1_t106" reading_order_no="37" segment_no="3" tag_type="table">0.288 (&lt;0.001**)</text>
<text top="226" left="60" width="28" height="7" font="font2" id="p1_t107" reading_order_no="38" segment_no="3" tag_type="table">Cyclin E</text>
<text top="226" left="358" width="14" height="7" font="font2" id="p1_t108" reading_order_no="39" segment_no="3" tag_type="table">1 (-)</text>
<text top="226" left="426" width="50" height="7" font="font2" id="p1_t109" reading_order_no="40" segment_no="3" tag_type="table">-0.094 (0.099)</text>
<text top="226" left="494" width="59" height="7" font="font2" id="p1_t110" reading_order_no="41" segment_no="3" tag_type="table">0.395 (&lt;0.001**)</text>
<text top="241" left="60" width="14" height="7" font="font2" id="p1_t111" reading_order_no="42" segment_no="3" tag_type="table">p27</text>
<text top="241" left="426" width="14" height="7" font="font2" id="p1_t112" reading_order_no="43" segment_no="3" tag_type="table">1 (-)</text>
<text top="241" left="494" width="62" height="7" font="font2" id="p1_t113" reading_order_no="44" segment_no="3" tag_type="table">-0.211 (&lt;0.001**)</text>
<text top="257" left="60" width="16" height="7" font="font2" id="p1_t114" reading_order_no="45" segment_no="3" tag_type="table">Ki67</text>
<text top="257" left="494" width="14" height="7" font="font2" id="p1_t115" reading_order_no="46" segment_no="3" tag_type="table">1 (-)</text>
<text top="270" left="61" width="494" height="10" font="font9" id="p1_t116" reading_order_no="47" segment_no="4" tag_type="text">P values are given in parentheses. a For tumour type (ductal, lobular, tubular), the χ 2 test was used. Otherwise, Pearson's correlation test was used.</text>
<text top="281" left="61" width="159" height="7" font="font2" id="p1_t117" reading_order_no="48" segment_no="4" tag_type="text">* P &lt; 0.05, ** P &lt; 0.01. ER, oestrogen receptor.</text>
</page>
</pdf2xml>
